- Published on
Ophthalmology – Arcus Senilis
Arcus senilis is a common ocular finding characterized by a yellowish-white ring of lipid deposition in the peripheral cornea, separated from the limbus by a narrow clear zone. It is most frequently seen in older adults and is considered a benign, age-related change that does not affect vision or require treatment. In younger individuals, however, the presence of arcus—often termed arcus juvenilis—may indicate underlying systemic conditions such as hyperlipidemia and increased cardiovascular risk.
The prevalence of arcus senilis increases with age, affecting a significant proportion of individuals over 50 years old, with estimates around 65%. It is more commonly observed in men and in individuals of African descent. While aging is the primary risk factor in older patients, early onset arcus is strongly associated with disorders of lipid metabolism, particularly familial hypercholesterolemia, an autosomal dominant condition. In such cases, the development of arcus reflects the duration of lipid abnormalities rather than their severity.
Pathophysiologically, arcus senilis results from the deposition of lipids—including cholesterol, cholesterol esters, triglycerides, and phospholipids—within the corneal stroma. These deposits occur primarily in both superficial (Bowman’s membrane) and deep (Descemet’s membrane) layers, forming characteristic wedge-shaped opacities that eventually merge into a circumferential ring. Despite these structural changes, corneal transparency in the visual axis remains unaffected, which is why vision is preserved.
Clinically, patients are usually asymptomatic and may notice only a change in the appearance of their eyes, sometimes describing a lighter ring around the iris. On examination, the arcus appears as a well-defined peripheral ring with a clear zone adjacent to the limbus. It typically begins as superior and inferior arcs that gradually extend to form a complete 360-degree ring. Slit-lamp examination helps to better visualize the depth and distribution of lipid deposits.
Although arcus senilis itself does not impair vision, its clinical significance lies in its association with systemic disease in younger patients. In individuals under 50 years of age, especially men, it is considered a marker for hyperlipidemia and may be associated with increased risk of coronary artery disease and cardiovascular mortality. In children, arcus may be linked to congenital ocular anomalies or inherited lipid disorders, necessitating further evaluation.
Diagnosis is primarily clinical, but in younger patients, laboratory evaluation including serum lipid profile is essential. Additional cardiovascular assessment may be warranted depending on risk factors, including evaluation for hypertension, diabetes, smoking history, and family history of cardiovascular disease. In some cases, further investigations such as electrocardiography or stress testing may be indicated.
The differential diagnosis includes other peripheral corneal rings or opacities such as the Kayser–Fleischer ring seen in Wilson’s disease, band keratopathy from calcium deposition, limbal girdle of Vogt, Terrien’s marginal degeneration, and corneal changes associated with metabolic disorders like lecithin-cholesterol acyltransferase deficiency. These conditions can usually be distinguished based on clinical appearance, location, associated symptoms, and systemic findings.
Management of arcus senilis itself is not required, as it is a benign and non-progressive condition in older adults. However, in patients younger than 50 years, identification of arcus should prompt evaluation for underlying lipid abnormalities and cardiovascular risk factors. Patient education is important, with reassurance provided to older individuals and appropriate counseling and referral offered to younger patients for systemic evaluation.
The prognosis is excellent in terms of ocular health, as arcus senilis does not affect vision. Its significance lies primarily as a potential clinical marker for systemic disease in younger individuals, where early detection and management of associated conditions can have important long-term health benefits.
Arcus senilis is a common ocular finding characterized by a yellowish-white ring of lipid deposition in the peripheral cornea, separated from the limbus by a narrow clear zone. It is most frequently seen in older adults and is considered a benign, age-related change that does not affect vision or require treatment. In younger individuals, however, the presence of arcus—often termed arcus juvenilis—may indicate underlying systemic conditions such as hyperlipidemia and increased cardiovascular risk.
The prevalence of arcus senilis increases with age, affecting a significant proportion of individuals over 50 years old, with estimates around 65%. It is more commonly observed in men and in individuals of African descent. While aging is the primary risk factor in older patients, early onset arcus is strongly associated with disorders of lipid metabolism, particularly familial hypercholesterolemia, an autosomal dominant condition. In such cases, the development of arcus reflects the duration of lipid abnormalities rather than their severity.
Pathophysiologically, arcus senilis results from the deposition of lipids—including cholesterol, cholesterol esters, triglycerides, and phospholipids—within the corneal stroma. These deposits occur primarily in both superficial (Bowman’s membrane) and deep (Descemet’s membrane) layers, forming characteristic wedge-shaped opacities that eventually merge into a circumferential ring. Despite these structural changes, corneal transparency in the visual axis remains unaffected, which is why vision is preserved.
Clinically, patients are usually asymptomatic and may notice only a change in the appearance of their eyes, sometimes describing a lighter ring around the iris. On examination, the arcus appears as a well-defined peripheral ring with a clear zone adjacent to the limbus. It typically begins as superior and inferior arcs that gradually extend to form a complete 360-degree ring. Slit-lamp examination helps to better visualize the depth and distribution of lipid deposits.
Although arcus senilis itself does not impair vision, its clinical significance lies in its association with systemic disease in younger patients. In individuals under 50 years of age, especially men, it is considered a marker for hyperlipidemia and may be associated with increased risk of coronary artery disease and cardiovascular mortality. In children, arcus may be linked to congenital ocular anomalies or inherited lipid disorders, necessitating further evaluation.
Diagnosis is primarily clinical, but in younger patients, laboratory evaluation including serum lipid profile is essential. Additional cardiovascular assessment may be warranted depending on risk factors, including evaluation for hypertension, diabetes, smoking history, and family history of cardiovascular disease. In some cases, further investigations such as electrocardiography or stress testing may be indicated.
The differential diagnosis includes other peripheral corneal rings or opacities such as the Kayser–Fleischer ring seen in Wilson’s disease, band keratopathy from calcium deposition, limbal girdle of Vogt, Terrien’s marginal degeneration, and corneal changes associated with metabolic disorders like lecithin-cholesterol acyltransferase deficiency. These conditions can usually be distinguished based on clinical appearance, location, associated symptoms, and systemic findings.
Management of arcus senilis itself is not required, as it is a benign and non-progressive condition in older adults. However, in patients younger than 50 years, identification of arcus should prompt evaluation for underlying lipid abnormalities and cardiovascular risk factors. Patient education is important, with reassurance provided to older individuals and appropriate counseling and referral offered to younger patients for systemic evaluation.
The prognosis is excellent in terms of ocular health, as arcus senilis does not affect vision. Its significance lies primarily as a potential clinical marker for systemic disease in younger individuals, where early detection and management of associated conditions can have important long-term health benefits.
0 Comments
